Help HCA ask for Federal Funding for Treatment and Prevention of HSV!

The landscape for Herpes treatment and prevention is, while the are glimmers of hope, very ugly. There are no public health interventions to stop transmission and no accurate test to diagnose asymptomatic infection. The treatment pipeline is slim, improving – yet slim. And NIH is investing less than 10 million a year in clinical researchContinue reading “Help HCA ask for Federal Funding for Treatment and Prevention of HSV!”

Hope for Herpes Keratitis Cure in China: Study results expected in 2022

In the global race for a Herpes cure, China is taking the lead. For the first time, transient gene-editing of the herpes simplex virus type 1 (HSV-1) using mRNA-based CRISPR was shown to cure herpes keratitis in mice. Chinese researchers reported in a paper published January 11, 2021 of Nature Biotechnology. In a paper publishedContinue reading “Hope for Herpes Keratitis Cure in China: Study results expected in 2022”

New HSV Advocates: A Starters Guide to Activism

Hello Herpes Advocates, We’re happy you’re here. We believe part of the reason there have been no advances in treatment or prevention in 40 years is due to stigma and lack of activism. There has never been a centralized advocacy effort for HSV until now. Getting started with Herpes Advocacy Step 1: Know the factsContinue reading “New HSV Advocates: A Starters Guide to Activism”

Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients

AiCuris AG, a German biotech company, is currently recruiting for their clinical trial on Pritelivir. Pritelivir is a highly anticipated new treatment for resistant Herpes Simplex Virus infections that cannot be managed with the available anti-virals. It is currently being tested for immune compromised patients only and, if proven safe and effective, could become aContinue reading “Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients”

Call for Herpes Advocates: Rally for a cure with us!

Want to rally for a cure with us? Why isn’t there a herpes cure or even a diagnostic test that works? Why have there been no treatment improvements in 40 years? Where there is a will, there is a way. When we organize, we make change happen. Join for our monthly advocacy status meeting andContinue reading “Call for Herpes Advocates: Rally for a cure with us!”

Advocates Call on FDA to Remove Faulty Tests for Herpes

It is widely recognized among providers of STI screening that serology tests for Herpes Simplex Virus types 1 & 2 are highly inaccurate and often lead to false positives. So much so, that HSV is often not included in standard STI screening, despite it being the largest STI in America with no effective treatment orContinue reading “Advocates Call on FDA to Remove Faulty Tests for Herpes”

National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget

Herpes Cure Advocacy confirms a national strategy and strategic plan for Herpes Simplex Virus Types 1 and 2 in the approved House FY 2022 budget. On page 245, the House FY budget report reads: National Strategy for Herpes Simplex Virus (HSV), Types 1 and 2.—The Committee recognizes that an estimated 1 in 3 Americans hasContinue reading “National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget”

Current Herpes Cure Research at Excision BioTherapeutics

Excision Bio has illustrated the possibility in developing a curative gene therapy using CRISPR in treating both active and latent HSV infection in the body. The company has stated that they plan to begin clinical trials in Q1 2023. Excision’s cutting edge CRISPR gene therapy platform is built on technology licensed from the Doudna LabContinue reading “Current Herpes Cure Research at Excision BioTherapeutics”